NicorandilThird Party Manufacturing in India

Nicorandil works by opening ATP-sensitive potassium channels and acting as a nitric oxide donor.

By opening potassium channels, it causes hyperpolarization of smooth muscle cells, which leads to relaxation and vasodilation of peripheral and coronary resistance arterioles. The nitrate-like effect involves stimulating guanylate cyclase, increasing intracellular cyclic GMP, and causing venous pooling. This dual biological effect helps the body reduce both preload and afterload on the heart, improving coronary blood flow.

Unlike standard nitrates, Nicorandil provides cardioprotection during ischemic events. It is effective for the management of angina pectoris.

Therapeutic Uses

Nicorandil is prescribed for the treatment of:

• Angina Pectoris: Prevention and long-term treatment of chronic stable angina.
• Ischemic Heart Disease: Relief of symptoms in patients with coronary heart disease.

Why Manufacturers Choose Nicorandil

Nicorandil represents a unique dual-action cardiovascular drug that has high demand in both domestic and export markets. Its specific action mechanism and efficacy in managing angina where standard therapies fall short make it a critical addition to cardiac product portfolios.

This makes Nicorandil one of the most sought-after molecules for third party manufacturing in India, with consistent demand from specialized cardiac franchise operators.